Dolutegravir and Montelukast sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dolutegravir (dolutegravir) and Montelukast sodium (montelukast sodium). Common drug interactions include bursitis among females and beta 2 microglobulin urine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Dolutegravir and Montelukast sodium. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Dolutegravir?

Dolutegravir has active ingredients of dolutegravir. eHealthMe is studying from 7,071 Dolutegravir users. Check the latest studies of Dolutegravir.

What is Montelukast sodium?

Montelukast sodium has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 26,093 Montelukast sodium users. Check the latest studies of Montelukast sodium.

On Jul, 06, 2026

42 people who take Dolutegravir and Montelukast sodium together, and have interactions are studied.

Dolutegravir and Montelukast sodium drug interactions.

What are the common drug interactions of Dolutegravir and Montelukast Sodium, by gender? *:

female:

Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Coeliac disease (simple food intolerance)
Constipation
Drug hypersensitivity
Drug ineffective
Drug intolerance (drug sensitivity)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Fluid retention (an abnormal accumulation of fluid in the blood)
Food allergy

male:

Beta 2 microglobulin urine increased
Blood creatinine increased
Blood triglycerides increased
Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
Irritable bowel syndrome
Tinea pedis (a contagious skin infection caused by the ringworm fungus)
Impetigo (contagious skin infection)
Sinusitis (inflammation of sinus)
Haematospermia (presence of blood in semen)

What are the common drug interactions of Dolutegravir and Montelukast Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Back pain
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Coeliac disease (simple food intolerance)
Constipation
Drug hypersensitivity
Drug ineffective
Drug intolerance (drug sensitivity)
Erythema (redness of the skin)
Fatigue (feeling of tiredness)
Fluid retention (an abnormal accumulation of fluid in the blood)

40-49:

n/a

50-59:

Back pain
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Food allergy
Headache (pain in head)
Hepatic enzyme increased
Hyperhidrosis (abnormally increased sweating)
Hypersensitivity
Hypertension (high blood pressure)
Immunodeficiency
Infusion related reaction

60+:

n/a

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 33 people, 78.57%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 31 people, 73.81%
Herpes Zoster: 26 people, 61.90%
Pain: 12 people, 28.57%
Hiv Infection: 7 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Dolutegravir and Montelukast sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously